ABSTRACT
Achieving and maintaining a competitive advantage in any industry is neither nor has it been an easy task. The pharmaceutical and food sectors have independent as well as related challenges as both are introduced at different stages in a life cycle. The pharma sector is at a maturity stage, while the nutra and food sectors in some countries are still at the growth and infancy stages. Hence, the challenges faced by both sectors need to be examined separately and together as the population has
Introduction ................................................................................................................3 Consumer Health .......................................................................................................4 Existence and Growth of the Pharma Sector .............................................................4 Challenges Faced by the Pharmaceutical Sector........................................................5 The Emerging Role of Nutrition along with the Pharmaceutical Sector ...................6 Challenges Faced by the Food Sectors ......................................................................7 Nurturing a Double-Vision Coexistence Model.........................................................8 Microbiome Theory: The Dysfunction and Disorder Relationship ...........................9 The Shift to Integrated (Holistic) Medicines ........................................................... 10 Advantages of Integrated Medicine ......................................................................... 10 Treatment of Medical Problems with Nutrition-Based Products ............................. 11 The Convergence of Pharma and Nutra ................................................................... 11 The Way Forward ..................................................................................................... 12
A Case for Evidence-Based Products ................................................................. 12 Prelicense Activities ....................................................................................... 12 Evidence Creation Activities .......................................................................... 12
A Case for the Care of Consumers ...................................................................... 13 A Case for Branding............................................................................................ 14
Conclusion ............................................................................................................... 14 References ................................................................................................................ 15
become more sophisticated and demanding, and is expecting more product innovations; legislation also needs to cope with the environment and become more reective and complex.
